Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam vs Levetiracetam in Pediatric Status Epilepticus
NCT07163572Completed
- Start
- Jan 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of brivaracetam in status epilepticus (SE) (2 arms). Primary endpoint: Cessation of seizures at 30 minutes. Started Jan 2025; status: completed.
02
Drugs
brivaracetam
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT07163572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07163572.